Rafi Aghababaian – In Memoriam
Despite several surgeries, clinical trial drugs and best efforts of doctors, Rafi Azad Aghababian, 38, of Calabasas, California, lost his twoyear battle to GIST on Jan. 22, 2005
Study: Gleevec Levels Decrease Over Time
Data raises concerns over long-term viability of lower Gleevec doses By Jerry Call with Norman Scherzer January, 2005 - One reason that side effects from Gleevec often get better over time is that levels of [...]